HOME › DRUGS › TOFACITINIB CITRATE
ACTIVE SUBSTANCE / INN

TOFACITINIB CITRATE

Brand name(s): XELJANZ XR, XELJANZ, TOFACITINIB CITRATE, TOFACITINIB
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA219442
ANDA218668
ACTIVE SUBSTANCE
Tofacitinib Citrate
REGULATORS
FDA
SPONSORS / MAH
PF PRISM CV, DEXCEL, SPECGX LLC
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
XELJANZNDA203214PF PRISM CVPrescription
TOFACITINIB CITRATEANDA218668DEXCELNone (Tentative Approval)
TOFACITINIB CITRATEANDA218668DEXCELDiscontinued
TOFACITINIBANDA219395SPECGX LLCNone (Tentative Approval)
TOFACITINIB CITRATEANDA219442BIOCON PHARMAPrescription
XELJANZ XRNDA208246PFIZERPrescription

FULL INTELLIGENCE ON TOFACITINIB CITRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →